Mineral BioSciences® Announces New Product For Blood Sugar Control
PHOENIX, Jan. 5, 2016 /PRNewswire/ -- Phoenix-based Mineral BioSciences® announces a ground-breaking new product, GlyDe® D. GlyDe® D stands for "Glycation Defense," a process which is crucial for lowering blood sugar. Utilizing their patented, proprietary ingredient, Totala® Ionic Mineral Complex, and enhancing it with Vitamin D3, GlyDe® D can be used to assist with reducing blood sugar levels and lowering glycated hemoglobin (A1C).
"GlyDe® D is an innovative product that will become a game-changer for individuals who want help managing their blood sugar naturally," said Luke Blotsky, managing partner and CEO of Mineral BioSciences®. "It meets and exceeds industry challenges by being a sustainable solution to a growing problem that a lot of people are not finding an easy solution for."
Glycation occurs when excess sugar molecules bond with protein and create "rogue" molecules known as Advanced Glycation End-Products (AGEs). AGEs attach to cells throughout the body and can become a primary cause for complications. Totala® Ionic Mineral Complex is a vital ingredient in the GlyDe® D supplement, as it helps the body block the formation of AGEs and protects tissues against the glycation process.
With the addition of Vitamin D3, GlyDe® D also works to increase the blood levels of this important, but also commonly deficient, nutrient. Many people that live with low blood sugar levels are lacking important vitamins and minerals such as Vitamin D. This particular vitamin is important as it helps boost certain gene production which destroys viruses, bacteria, and other germs.
GlyDe® D is the first of its kind on the market because of its anti-glycation product patent. This patent was first filed in October 2008. It protects the exclusive composition, which has displayed anti-glycation activities and is used to treat or prevent glycation events in humans and animals.
GlyDe® D is now available for purchase online, and will be available in select retail stores early this year. The supplement contains 60 softgels, which should be taken one to two times a day after a meal. Consumers can purchase the supplement at www.glyded.com or through Amazon.
Clinical studies have shown that by disrupting the glycation process, GlyDe® D is able to assist with lowering blood glucose and reducing glycated hemoglobin levels. GlyDe® D can also reduce oxidative stress, which is central to the damage caused by AGEs, resulting in lower levels of free radicals that can damage tissues throughout the body.
GlyDe® D is an all-natural product and is Generally Recognized as Safe (GRAS) Affirmed. It is also Vegetarian, Gluten Free, Caffeine & Guarana Free, Sugar & Sucralose Free, and Soy & GMO Free.
For more information about GlyDe® D visit www.glyded.com.
Clinical studies and images are available upon request.
Referenced US Patent Numbers are as follows: 9044417, 8927031.
About Mineral BioSciences®
For more than 20 years, Mineral BioSciences® has been providing brand-enriching solutions on a domestic and international basis, with nutrient-rich minerals as a signature ingredient, that have proven nutritional and biological health benefits based on their bioavailable properties. Products that have been developed through our patented extraction methods and processing are Generally Recognized as Safe (GRAS) Affirmed and are refined in state-of-the-art USDA Certified laboratories. Mineral BioSciences® was founded by Roger Blotsky and is based on the belief that "Nature Knows Best®," considering both himself and the company "stewards of the environment." To learn more about Mineral BioSciences® visit www.mineralbiosciences.com.
SOURCE Mineral BioSciences
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article